WHEN BMSN CLUCKED THEIR INTEREST IN ENTB BY GIVING A HUGE AMOUNT OF SHARES AWAY TO COVER DEBT AND LAW SUITS AN ACCOUNTING CREDIT WAS GENERATED ON THE BALANCE SHEET THAT WITHOUT UNDERSTANDING THE MATH MAKES IT LOOK AS THOUGH BMSN MADE 41 MILL BUT IN FACT IT IS JUST SOME FANCY ACCOUNTING MUMBO JUMBO AND BMSN HAS NO REVENUE FROM ANY ACTUAL SALES OF ANYTHING FOR OVER FIVE YEARS. BMSN WAS .007-.008 6 MONTHS AGO BEFORE IT TANKED TO .0006. GLAD TO SEE MONEY MADE ON FLIP OR SUB-SUB PENNY BUYS BUT THAT STILL DOES NOT ERASE THE FRAUD THAT BMSN CEO KOOS HAS COMMITED OR MAKE BMSN A REAL BIOTECH. BASED ON BMSN TRACK RECORD THIS IS STILL A SCAM. A TEN BAG WHEN BMSN IS .0006 TO .006 DOES NOT VALIDATE ANY OF BMSN'S ACTIONS OR MAKE BMSN A 100 MILLION DOLLAR PROFITABLE COMPANY AT ALL. CONGRATS TO ALL TTYL XOX
8-K Filing As of December 31, 2012 Bio-Matrix Scientific Group, Inc. (the “Company”) has 1,035,911,549 of its common stock issued and outstanding
(“Common Shares Out”). As of December 31, 2012, of the common [color=red]shares issued and outstanding, 12,718,293 of these shares were held by affiliates (“Affiliate Shares” ) as affiliate is defined in Rule 144 promulgated under the Securities Act of 1933
The Affiliate Shares include 8,454,994 common shares owned by David Koos (the Company’s Chairman and CEO) as well as 4,159,085 common shares owned by Bombardier Pacific Ventures Inc., which is wholly owned by David Koos, 104,160 common shares owned by the AFN Trust for which David Koos serves as Trustee and 54 common shares held by the BMXP Holdings Shareholder’s Business Trust for which David Koos serves as Trustee.